| pubmed-article:10871467 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C0015943 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C1156182 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C0015944 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C0025543 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:10871467 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:10871467 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10871467 | pubmed:dateCreated | 2000-7-25 | lld:pubmed |
| pubmed-article:10871467 | pubmed:abstractText | Increased matrix metalloproteinase 2 expression and activity are associated with premature rupture of fetal membranes. A proapoptotic protein produced in response to deoxyribonucleic acid fragmentation, p53, can bind to the matrix metalloproteinase 2 gene promoter and cause increased gene expression. It promotes apoptosis by inducing the expression of the proapoptotic bax gene and inhibiting the antiapoptotic bcl-2 gene. This study was undertaken to investigate the expression pattern of apoptotic elements in pregnancy complications that may cause increased expression of the gene for matrix metalloproteinase 2. | lld:pubmed |
| pubmed-article:10871467 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10871467 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10871467 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10871467 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10871467 | pubmed:issn | 0002-9378 | lld:pubmed |
| pubmed-article:10871467 | pubmed:author | pubmed-author:BryantCC | lld:pubmed |
| pubmed-article:10871467 | pubmed:author | pubmed-author:MenonRR | lld:pubmed |
| pubmed-article:10871467 | pubmed:author | pubmed-author:LombardiS JSJ | lld:pubmed |
| pubmed-article:10871467 | pubmed:author | pubmed-author:FortunatoS... | lld:pubmed |
| pubmed-article:10871467 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10871467 | pubmed:volume | 182 | lld:pubmed |
| pubmed-article:10871467 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10871467 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10871467 | pubmed:pagination | 1468-76 | lld:pubmed |
| pubmed-article:10871467 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:meshHeading | pubmed-meshheading:10871467... | lld:pubmed |
| pubmed-article:10871467 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10871467 | pubmed:articleTitle | Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. | lld:pubmed |
| pubmed-article:10871467 | pubmed:affiliation | Maternal-Fetal Group and the Perinatal Research Center of The Women's Health Research and Education Foundation, Nashville, TN 37203, USA. | lld:pubmed |
| pubmed-article:10871467 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10871467 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10871467 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10871467 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10871467 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10871467 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10871467 | lld:pubmed |
